Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients

Stopped early

Conditions studied: Stable Coronary Artery Disease (CAD), Myocardial Infarction

In brief

THis study is intended to provide contemporary data on the burden of disease in patients 1 to 3 years post-MI, including a description of patient characteristics, current treatment patterns, rate of major CV events, and healthcare resource utilization in a 'real world' patient population at high atherothrombotic risk.

Key facts

Study ID

NCT01866904

Run by

AstraZeneca

People needed

9284

Starts

2013-06-19

Expected to finish

2017-03-31

Last updated by the study team

2018-09-04

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Stable CAD patients aged 50 years or older with documented history of presumed spontaneous MI with their most recent MI occurring 1 to 3 years prior to enrollment and have at least 1 of the following risk factors: age ≥ 65 years; diabetes mellitus requiring medication; documented history of a second prior presumed spontaneous MI (>1 year ago); documented history of angiographic evidence of multivessel coronary artery disease; chronic renal dysfunction.

You may not qualify if…

• Presence of serious co-morbidities in the opinion of the investigator which may limit life expectancy (<1 year)
• Current participation in a blinded randomized clinical trial.
• Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient
• Patients receiving treatment of ticagrelor beyond 12 months, or off label use of ticagrelor.

Where it is running

• Research Site — Los Angeles, California, United States
• Research Site — Santa Ana, California, United States
• Research Site — Torrance, California, United States
• Research Site — Ventura, California, United States
• Research Site — Clearwater, Florida, United States
• Research Site — Miami, Florida, United States
• Research Site — Tallahassee, Florida, United States
• Research Site — Tucker, Georgia, United States
• Research Site — Arlington Heights, Illinois, United States
• Research Site — Englewood, Illinois, United States
• Research Site — Lebanon, Indiana, United States
• Research Site — Auburn, Maine, United States
• Research Site — Bangor, Maine, United States
• Research Site — Columbia, Maryland, United States
• Research Site — Jackson, Michigan, United States
• Research Site — Minneapolis, Minnesota, United States
• Research Site — Manhasset, New York, United States
• Research Site — Chapel Hill, North Carolina, United States
• Research Site — Durham, North Carolina, United States
• Research Site — Sandusky, Ohio, United States
• Research Site — Abington, Pennsylvania, United States
• Research Site — Doylestown, Pennsylvania, United States
• Research Site — Pittsburgh, Pennsylvania, United States
• Research Site — Sayre, Pennsylvania, United States
• Research Site — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.